Clinical Trial Update: A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating Endostar with chemotherapy followed by maintenance therapy for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Simcere Pharmaceutical Co., Ltd | Conditions: Non-small Cell Lung Cancer (NSCLC) | Phase 4 | Status: UNKNOWN